首页 | 本学科首页   官方微博 | 高级检索  
检索        

低分子肝素治疗脑梗死的临床疗效观察
引用本文:叶凌,项静燕,王珏,张进,吕善庆.低分子肝素治疗脑梗死的临床疗效观察[J].江苏大学学报(医学版),2002,12(4):359-360.
作者姓名:叶凌  项静燕  王珏  张进  吕善庆
作者单位:1. 贵阳市花溪区人民医院神经内科,贵州,贵阳,550025
2. 上海市第六人民医院神经内科,上海,200233
摘    要:目的:探讨低分子肝素治疗脑梗死的临床疗效。方法:选取脑梗死患者138例,随机分为治疗组68例,对照组70例。对照组予丹参10ml及胞磷胆碱1.0g分别加入0.9%NS 250ml静脉点滴,1次/d为基础治疗,治疗组在对照组的基础治疗上加用低分子肝素4100IU脐旁皮下注射,2次/d,治疗10d。结果:低分子肝素治疗组总有效率86.76%,对照组总有效率71.43%,治疗组疗效明显优于对照组(P<0.05)。结论:低分子肝素治疗急性脑梗死安全有效。

关 键 词:低分子肝素  脑梗死  疗效
文章编号:1671-7783(2002)04-0359-02
修稿时间:2002年4月19日

Clinical Observations of the Therapeutic Effect of Low-molecular-weight Heparin in Treatment of Cerebral Infarction
YE Ling,XIANG Jing yan,WANG Jue,et al.Clinical Observations of the Therapeutic Effect of Low-molecular-weight Heparin in Treatment of Cerebral Infarction[J].Journal of Jiangsu University Medicine Edition,2002,12(4):359-360.
Authors:YE Ling  XIANG Jing yan  WANG Jue  
Abstract:Objective:To study the therapeutic effect of the Low molecular weight heparin on cerebral infarction. Method:138 cases of cerebral infarction were randomly divided into two groups (1)the teatment group (70 cases) was given 10 ml of salvia miltiorrhiza. With 1.0 g of citicoline and 0.9%of NS 250 ml iv. gtt qd. (2)the control group (68 cases) was given 4 100 IU of low molecular weight heparin sc bid for 10 days. The other therapies in these two groups were the same.Result:The total effective rate is 86.76% in the group with low molecular weight heparin, and 71.43% in the control group. There is a significant difference between the two groups ( P <0.05). Conclusion:Low molecular weight heparin is an effective and safe drug in the treatment of cerebral infarction.
Keywords:Low  molecular  weight heparin  Cerebral Infarction  Therapeutic effect
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号